| Members |
targetComponentId |
| Non-surgical urinary biopsy NOS |
Non-surgical urinary biopsy |
| Non-surgical urinary biopsy NOS |
Non-surgical urinary biopsy |
| Non-surgical vascular biopsy NOS |
Non-surgical vascular biopsy |
| Non-surgical vascular biopsy NOS |
Non-surgical vascular biopsy |
| uøm processus mastoideus |
Mastoid non-tender |
| ikke-ømt ar i gravid uterus |
Scar of gravid uterus non-tender (situation) |
| uømme testes |
Testes non-tender (situation) |
| Non-urgent hospital admission unspecified |
Non-urgent hospital admission |
| Non-urgent hospital admission unspecified |
Non-urgent hospital admission |
| Nonalcoholic fatty liver |
The presence of metabolic dysfunction-associated steatotic liver disease (MASLD) in the absence of steatohepatitis. |
| Nonalcoholic fatty liver |
The presence of metabolic dysfunction-associated steatotic liver disease (MASLD) in the absence of steatohepatitis. |
| Ikke-allopatisk morfologisk forandring |
Impaired or altered function of related components of the body framework system: skeletal, arthrodial and myofascial structures, and their related vascular, lymphatic and neural elements. It is characterized by positional asymmetry, restricted range of motion, tissue texture abnormalities, and/or tenderness. The positional and motion aspects of somatic dysfunction are generally described by: (1) The position of a body part as determined by palpation and referenced to its defined adjacent structure, (2) The directions in which motion is freer, and (3) The directions in which motion is restricted. Somatic dysfunction is treatable using osteopathic manipulative treatment. |
| Ikke-allopatisk morfologisk forandring i akromioklavikulærregion |
Somatic dysfunction of acromioclavicular region (finding) |
| ikke-allopatisk morfologisk forandring i ryggen |
Somatic dysfunction of back region (finding) |
| Nonallopathic lesion of cervical region |
Cervical somatic dysfunction |
| Ikke-allopatisk morfologisk forandring i cervikotorakalregionen |
Impaired or altered function of related components of the body framework system: skeletal, arthrodial and myofascial structures, and their related vascular, lymphatic and neural elements. It is characterized by positional asymmetry, restricted range of motion, tissue texture abnormalities, and/or tenderness. The positional and motion aspects of somatic dysfunction are generally described by: (1) The position of a body part as determined by palpation and referenced to its defined adjacent structure, (2) The directions in which motion is freer, and (3) The directions in which motion is restricted. Somatic dysfunction is treatable using osteopathic manipulative treatment. |
| ikke-allopatisk læsion af cartilago costalis |
Somatic dysfunction of costochondral region (finding) |
| ikke-allopatisk læsion i caput costae-område |
Somatic dysfunction of costovertebral joint structure (finding) |
| Ikke-allopatisk morfologisk forandring i hofteregionen |
Somatic dysfunction of hip region (finding) |
| Ikke-allopatisk læsion i underekstremiteter |
Somatic dysfunction of lower limb (finding) |
| Ikke-allopatisk morfologisk forandring i lumbosakralregionen |
Somatic dysfunction of lumbar region (finding) |
| Ikke-allopatisk morfologisk forandring i occipitocervikalregionen |
Somatic dysfunction of occipitocervical region (finding) |
| Ikke-allopatisk morfologisk forandring i regio pubica |
Somatic dysfunction of pubic region (finding) |
| Ikke-allopatisk morfologisk forandring i truncusregionen |
Somatic dysfunction of region of trunk (finding) |
| ikke-allopatisk morfologisk forandring i sakrokokcygealregionen |
Somatic dysfunction of sacrococcygeal region (finding) |
| ikke-allopatisk morfologisk forandring i sakroiliakalregionen |
Somatic dysfunction of sacroiliac region (finding) |
| ikke-allopatisk læsion af området omkring synchondrosis xiphisternalis |
Somatic dysfunction of sternochondral region (finding) |
| Ikke-allopatisk morfologisk forandring i sternoklavikulærregion |
Somatic dysfunction of sternoclavicular region (finding) |
| Ikke-allopatisk morfologisk forandring i armene |
Impaired or altered function of related components of the body framework system: skeletal, arthrodial and myofascial structures, and their related vascular, lymphatic and neural elements. It is characterized by positional asymmetry, restricted range of motion, tissue texture abnormalities, and/or tenderness. The positional and motion aspects of somatic dysfunction are generally described by: (1) The position of a body part as determined by palpation and referenced to its defined adjacent structure, (2) The directions in which motion is freer, and (3) The directions in which motion is restricted. Somatic dysfunction is treatable using osteopathic manipulative treatment. |
| Ikke-allopatisk morfologisk forandring i cervikalregionen |
Cervical somatic dysfunction |
| Ikke-allopatisk morfologisk forandring i hovedregionen |
Somatic dysfunction of head region (finding) |
| Ikke-allopatisk morfologisk forandring i benene |
Somatic dysfunction of lower limb (finding) |
| Ikke-allopatisk morfologisk forandring i lumbalregionen |
Somatic dysfunction of lumbar region (finding) |
| ikke-allopatisk morfologisk forandring i bækkenområdet |
Impaired or altered function of related components of the body framework system: skeletal, arthrodial and myofascial structures, and their related vascular, lymphatic and neural elements. It is characterized by positional asymmetry, restricted range of motion, tissue texture abnormalities, and/or tenderness. The positional and motion aspects of somatic dysfunction are generally described by: (1) The position of a body part as determined by palpation and referenced to its defined adjacent structure, (2) The directions in which motion is freer, and (3) The directions in which motion is restricted. Somatic dysfunction is treatable using osteopathic manipulative treatment. |
| Ikke-allopatisk morfologisk forandring i brystkassen |
Somatic dysfunction of thoracic region (finding) |
| ikke-allopatisk morfologisk forandring i regio sacralis |
Somatic dysfunction of sacral region (finding) |
| Ikke-allopatisk morfologisk forandring i torakalregionen |
Somatic dysfunction of thoracic region (finding) |
| Ikke-allopatisk morfologisk forandring i torakolumbalregionen |
Impaired or altered function of related components of the body framework system: skeletal, arthrodial and myofascial structures, and their related vascular, lymphatic and neural elements. It is characterized by positional asymmetry, restricted range of motion, tissue texture abnormalities, and/or tenderness. The positional and motion aspects of somatic dysfunction are generally described by: (1) The position of a body part as determined by palpation and referenced to its defined adjacent structure, (2) The directions in which motion is freer, and (3) The directions in which motion is restricted. Somatic dysfunction is treatable using osteopathic manipulative treatment. |
| Ikke-allopatisk morfologisk forandring i overekstremiteter |
Impaired or altered function of related components of the body framework system: skeletal, arthrodial and myofascial structures, and their related vascular, lymphatic and neural elements. It is characterized by positional asymmetry, restricted range of motion, tissue texture abnormalities, and/or tenderness. The positional and motion aspects of somatic dysfunction are generally described by: (1) The position of a body part as determined by palpation and referenced to its defined adjacent structure, (2) The directions in which motion is freer, and (3) The directions in which motion is restricted. Somatic dysfunction is treatable using osteopathic manipulative treatment. |
| Nonallopathic lesion, NEC |
Impaired or altered function of related components of the body framework system: skeletal, arthrodial and myofascial structures, and their related vascular, lymphatic and neural elements. It is characterized by positional asymmetry, restricted range of motion, tissue texture abnormalities, and/or tenderness. The positional and motion aspects of somatic dysfunction are generally described by: (1) The position of a body part as determined by palpation and referenced to its defined adjacent structure, (2) The directions in which motion is freer, and (3) The directions in which motion is restricted. Somatic dysfunction is treatable using osteopathic manipulative treatment. |
| Nonbacterial gastroenteritis |
Infectious gastroenteritis |
| Nondependent alcohol abuse NOS |
Nondependent harmful pattern of use of alcohol (disorder) |
| Nondependent alcohol abuse, unspecified |
Nondependent harmful pattern of use of alcohol (disorder) |
| ikke-afhængigt misbrug af stof af antidepressiv type, ikke nærmere specificeret |
Harmful pattern of use of antidepressant |
| ikke-afhængigt misbrug af antidepressivt stof i remission |
Nondependent harmful pattern of use of antidepressant in remission (disorder) |
| ikke-afhængigt misbrug af antidepressivt stof, kontinuerligt |
Continuous nondependent harmful pattern of use of antidepressant (disorder) |
| ikke-afhængig skadelig brug af antidepressivt stof, episodisk |
Episodic nondependent harmful pattern of use of antidepressant (disorder) |
| ikke-afhængigt misbrug af antidepressivt stof, uspecificeret |
Harmful pattern of use of antidepressant |
| Nondependent cannabis abuse NOS |
Nondependent harmful pattern of use of cannabis (disorder) |
| Nondependent cannabis abuse, unspecified |
Nondependent harmful pattern of use of cannabis (disorder) |
| Nondependent cocaine abuse NOS |
Nondependent harmful pattern of use of cocaine |
| Nondependent cocaine abuse, unspecified |
Nondependent harmful pattern of use of cocaine |
| Nondependent hallucinogen abuse NOS |
Nondependent harmful pattern of use of hallucinogen (disorder) |
| Nondependent hallucinogen abuse, unspecified |
Nondependent harmful pattern of use of hallucinogen (disorder) |
| ikke-afhængig blandet skadelig brug af stof |
Nondependent harmful pattern of mixed substance use (disorder) |
| Nondependent mixed drug abuse NOS |
Nondependent harmful pattern of mixed substance use (disorder) |
| ikke-afhængig blandet skadelig brug af stof i remission |
Nondependent harmful pattern of mixed substance use in remission (disorder) |
| ikke-afhængigt blandet stofmisbrug, kontinuerligt |
Continuous nondependent harmful pattern of mixed substance use (disorder) |
| ikke-afhængig blandet brug af skadeligt stof, episodisk |
Episodic nondependent harmful pattern of mixed substance use (disorder) |
| Nondependent mixed drug abuse, unspecified |
Nondependent harmful pattern of mixed substance use (disorder) |
| Nondependent opioid abuse NOS |
Nondependent harmful pattern of use of opioid |
| Nondependent opioid abuse, unspecified |
Nondependent harmful pattern of use of opioid |
| Nondependent other drug abuse |
Nondependent harmful pattern of substance use |
| Nondependent other drug abuse NOS |
Nondependent harmful pattern of substance use |
| Nondependent other drug abuse in remission |
Nondependent harmful pattern of substance use in remission |
| Nondependent other drug abuse, continuous |
Continuous nondependent harmful pattern of substance use (disorder) |
| Nondependent other drug abuse, episodic |
Episodic nondependent harmful pattern of substance use (disorder) |
| Nondependent other drug abuse, unspecified |
Nondependent harmful pattern of substance use |
| Nonexudative senile macular retinal degeneration |
Nonexudative age-related macular degeneration (disorder) |
| non-invasivt intracystisk karcinom |
Encapsulated papillary carcinoma (morphologic abnormality) |
| Nonpyogenic thrombosis of intracranial venous sinus |
Nonpyogenic thrombosis of intracranial venous sinus |
| uspecifikt abdominalt symptom |
Finding of abdomen |
| Nonspecific antibody |
Nonspecific immunoglobulin (substance) |
| Nonspecific surgical approaches |
Procedural approach |
| tryksår, der ikke kan stadieinddeles |
Unstageable pressure injury |
| noradrenalinhydrogentartrat 2 mg/ml koncentrat til infusionsvæske, ampul a 20 ml |
Noradrenaline (as noradrenaline bitartrate) 1 mg/mL solution for injection |
| noradrenalinhydrogentartrat 2 mg/ml koncentrat til infusionsvæske, ampul a 2 ml |
Noradrenaline (as noradrenaline bitartrate) 1 mg/mL solution for injection |
| norfloxacin 0,3 % opløsning |
Norfloxacin only product in ocular dose form |
| Normalt bevægeudslag ved aktiv ekstension af ankel |
Normal active range of ankle plantar flexion (finding) |
| Normalt bevægeudslag ved aktiv fleksion af ankel |
Normal active range of ankle dorsiflexion |
| normale laboratoriefund |
Measurement finding within reference range |
| Normalt bevægeudslag ved passiv ekstension af ankel |
Normal passive range of ankle plantar flexion |
| Normalt bevægeudslag ved passiv fleksion af ankel |
Normal passive range of ankle dorsiflexion |
| Normal periodontal tissue surrounding dental implant |
Normal oral mucous membrane and osseointegrated bone tissue surrounding dental implant (finding) |
| Normal fysisk holdning |
Body posture normal |
| Normal retraktion af øvre segment |
Normal retraction of upper uterine segment |
| fysiologisk saltvand |
Sodium chloride only product |
| fysiologisk saltvand + kaliumchlorid |
Product containing only potassium chloride and sodium chloride (medicinal product) |
| operation på vagina ad modum Norman Miller |
Fixation of vagina |
| Normosomatisk sialidose |
Sialidosis type 1 (ST-1) is a very rare lysosomal storage disease, and is the normosomatic form of sialidosis, characterized by gait abnormalities, progressive visual loss, bilateral macular cherry red spots and myoclonic epilepsy and ataxia, that usually presents in the second to third decade of life. |
| North American blastomycosis |
Blastomycosis |
| Nordamerikansk kutan blastomykose |
Cutaneous blastomycosis |
| North American disseminated blastomycosis |
Disseminated blastomycosis |
| Nordamerikansk okulær blastomykose |
Ocular blastomycosis (disorder) |
| Nordamerikansk pulmonal blastomykose |
Pulmonary blastomycosis |
| North American urogenital blastomycosis |
Urogenital blastomycosis (disorder) |
| Nortriptyline hydrochloride 50mg |
Nortriptyline (as nortriptyline hydrochloride) 50 mg oral capsule |
| Nortriptyline hydrochloride 75mg |
Product containing precisely nortriptyline (as nortriptyline hydrochloride) 75 milligram/1 each conventional release oral capsule (clinical drug) |
| Nose flap |
Flap (substance) |
| Nose lesion excised NOS |
Nose lesion excised |
| Nose lesion excised NOS |
Nose lesion excised |
FHIR